0001156039-24-000031.txt : 20240305
0001156039-24-000031.hdr.sgml : 20240305
20240305162707
ACCESSION NUMBER: 0001156039-24-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kendrick Charles Morgan JR
CENTRAL INDEX KEY: 0001887908
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16751
FILM NUMBER: 24720933
MAIL ADDRESS:
STREET 1: 220 VIRGINIA AVE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevance Health, Inc.
CENTRAL INDEX KEY: 0001156039
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 352145715
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
BUSINESS PHONE: 8003311476
MAIL ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
FORMER COMPANY:
FORMER CONFORMED NAME: Anthem, Inc.
DATE OF NAME CHANGE: 20141202
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT, INC
DATE OF NAME CHANGE: 20100105
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT INC
DATE OF NAME CHANGE: 20041130
4
1
wk-form4_1709674012.xml
FORM 4
X0508
4
2024-03-01
0
0001156039
Elevance Health, Inc.
ELV
0001887908
Kendrick Charles Morgan JR
220 VIRGINIA AVE
INDIANAPOLIS
IN
46204
0
1
0
0
EVP & President, Commercial
0
Common Stock
2024-03-01
4
F
0
1484
499.11
D
13764
D
Common Stock
2024-03-01
4
A
0
2154
0
A
15918
D
Common Stock
2024-03-01
4
A
0
2354
0
A
18272
D
Employee Stock Option (Right to Buy)
499.11
2024-03-01
4
A
0
8312
0
A
2034-03-01
Common Stock
8312
8312
D
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Represents restricted share units. Restrictions lapse as follows:718 shares on 3/1/2025, 3/1/2026, and 3/1/2027.
Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.
/s/ Kathleen S. Kiefer, Attorney in fact
2024-03-05